| 发明名称 |
COMPOSITION AND METHOD TO IMPROVE BLOOD LIPID PROFILES AND REDUCE LOW DENSITY LIPOPROTEIN (LDL) PER-OXIDATION IN HUMANS USING ALGAE BASED OILS AND ASTAXANTHIN |
| 摘要 |
In accordance with a non-limiting example, an algae based oil is used in place of a krill oil to treat low density lipoprotein (LDL) oxidation in humans by administering a therapeutic amount of a dietary supplement composition comprising an algae based oil comprising glycolipids and phospholipids and Eicosapentaenoic (EPA) fatty acids in combination with astaxanthin derived from Haematococcus pluvialis (Hp) in an oral dosage form, wherein the astaxanthin derived from Haematococcus pluvialis (Hp) is 0.1 to 2.7 percent by weight of the algae based oil. |
| 申请公布号 |
US2015320812(A1) |
申请公布日期 |
2015.11.12 |
| 申请号 |
US201514806973 |
申请日期 |
2015.07.23 |
| 申请人 |
U.S. NUTRACEUTICALS, LLC d/b/a Valensa International |
发明人 |
MINATELLI John A.;Hill W. Stephen;Moerck Rudi E. |
| 分类号 |
A61K36/05;A61K31/122;A23L1/30;A61K31/70;A61K31/66;A61K36/02;A61K31/202 |
主分类号 |
A61K36/05 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A dietary supplement composition to treat low density lipoprotein (LDL) oxidation in humans, wherein the dietary supplement composition comprises a therapeutic amount of algae based oil in combination with astaxanthin derived from Haematococcus pluvialis (Hp) in an oral dosage form, wherein the astaxanthin derived from Haematococcus pluvialis (Hp) is 0.1 to 2.7 percent by weight of the algae based oil. |
| 地址 |
Eustis FL US |
